Healthy longevity at the cellular level
The Institute's second direction is gerontology research aimed at supporting healthy longevity, preserving quality of life and preventing age-related changes.
Shaping the direction
Clinical studies showed that, in addition to its antitumour action, the drug has a positive effect on the body's overall vital resources, reduces disease-related intoxication and supports the functioning of organs and systems.
In addition to its antitumour activity, the drug has shown an increase in lifespan in experimental models. This became one of the reasons for developing research in gerontology.
Targeting the fundamental mechanisms of ageing
- 01
Cellular detoxification
Deep detoxification of cells and clearance of cellular "waste", including lipofuscin — a pigment that accumulates with age.
- 02
Intercellular environment
Restoring the intercellular environment in which cells and tissues function.
- 03
DNA structure
A positive effect on restoring healthy DNA structure.
Research at the Institute of Gerontology
The D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine studied the drug's effect on survival under stress and on lifespan, as well as on lipofuscin clearance and the ultrastructure of neurons.
Preliminary results of pilot studies of the technology's effect on human health indicate a comprehensive rejuvenating effect on the body: a slower pace of functional ageing, a lower functional (biological) age, improved cognitive activity, attention and mental and physical performance, and lower blood cholesterol levels.
The results of preclinical studies point to the potential of the drug for healthy longevity.
Preclinical research completed
Preclinical research has been completed in full and demonstrated the high efficacy, non-toxicity and safety of the technology. It aims not only to extend lifespan but also to preserve a high quality of life and functional health.
Research materials are provided to partners once the terms of cooperation have been agreed and an NDA has been signed.
Interested in ageing research?
We welcome dialogue with research groups and institutions working on the biology of ageing.